Table 1. Binding Affinities at the Opioid Receptors and Calculated Physicochemical Properties of 6-Amino Acid (2–21)- and 6-Dipeptide-Substituted Derivatives (22a/b and 23a), and Reference Compound 1.
opioid
receptor binding Ki (nM)a |
physicochemical propertiesb | |||||
---|---|---|---|---|---|---|
compd | amino acid substitution at position 6 | MOR | DOR | KOR | Ki ratio MOR/DOR/KOR | c log D7.4 |
1c | 0.10 ± 0.01 | 4.80 ± 0.22 | 10.2 ± 2.0 | 1/48/102 | 0.48 | |
2ac | α-Gly | 0.89 ± 0.09 | 15.4 ± 1.4 | 43.2 ± 7.0 | 1/7/49 | –3.35 |
2bc | β-Gly | 0.83 ± 0.02 | 7.86 ± 0.64 | 44.8 ± 0.1 | 1/9.5/54 | –3.35 |
3ac | α-l-Ala | 0.77 ± 0.09 | 26.9 ± 0.8 | 142 ± 43 | 1/35/184 | –2.81 |
3bc | β-l-Ala | 1.90 ± 0.08 | 7.71 ± 0.94 | 63.7 ± 7.8 | 1/4.1/34 | –2.81 |
4ac | α-l-Phe | 0.95 ± 0.07 | 3.67 ± 0.32 | 28.5 ± 4.2 | 1/3.9/30 | –1.13 |
4bc | β-l-Phe | 2.58 ± 0.09 | 1.03 ± 0.13 | 151 ± 17 | 1/0.4/59 | –1.13 |
5ad | α-Gly | 0.19 ± 0.02 | 0.22 ± 0.02 | 0.73 ± 0.01 | 1/1.2/3.8 | –0.85 |
5bd | β-Gly | 0.16 ± 0.02 | 0.19 ± 0.01 | 0.81 ± 0.03 | 1/1.2/5.1 | –0.85 |
6a | α-l-Ser | 2.21 ± 0.02 | 5.32 ± 0.39 | 196 ± 24 | 1/2.4/89 | –3.89 |
6b | β-l-Ser | 2.14 ± 0.03 | 5.29 ± 0.31 | 152 ± 15 | 1/2.5/71 | –3.89 |
7a | α-l-Val | 3.16 ± 0.25 | 3.91 ± 0.30 | 325 ± 19 | 1/1.2/103 | –1.94 |
7b | β-l-Val | 3.04 ± 0.12 | 3.52 ± 0.04 | 305 ± 39 | 1/1.2/100 | –1.94 |
8a | α-l-Lys | 0.19 ± 0.04 | 1.27 ± 0.42 | 12.6 ± 1.3 | 1/6.7/66 | –5.57 |
8b | β-l-Lys | 0.53 ± 0.09 | 3.34 ± 0.46 | 33.7 ± 4.1 | 1/6.3/64 | –5.57 |
9a | α-l-Tyr | 0.83 ± 0.04 | 2.18 ± 0.98 | 39.5 ± 0.2 | 1/2.6/48 | –1.41 |
9b | β-l-Tyr | 3.20 ± 0.55 | 3.89 ± 0.64 | 186 ± 33 | 1/1.2/58 | –1.41 |
10a | α-l-Trp | 0.36 ± 0.01 | 1.02 ± 0.12 | 25.1 ± 9.3 | 1/2.8/70 | –1.03 |
10b | β-l-Trp | 0.65 ± 0.09 | 1.19 ± 0.40 | 8.66 ± 0.64 | 1/1.8/13 | –1.03 |
11a | α-l-Asn | 1.17 ± 0.07 | 3.37 ± 0.21 | 74.0 ± 9.7 | 1/2.9/63 | –4.29 |
11b | β-l-Asn | 1.26 ± 0.05 | 2.25 ± 0.11 | 103 ± 10 | 1/1.8/82 | –4.29 |
12a | α-l-Gln | 3.24 ± 0.14 | 5.13 ± 0.52 | 351 ± 66 | 1/1.6/108 | –4.04 |
12b | β-l-Gln | 2.48 ± 0.30 | 4.87 ± 0.76 | 290 ± 3 | 1/2.0/117 | –4.04 |
13a | α-l-Asp | 1.36 ± 0.05 | 14.6 ± 3.6 | 50.2 ± 9.2 | 1/11/37 | –5.64 |
13b | β-l-Asp | 3.42 ± 0.05 | 22.6 ± 2.2 | 351 ± 43 | 1/6.6/103 | –5.64 |
14a | α-l-Glu | 1.45 ± 0.09 | 9.03 ± 0.70 | 87.2 ± 4.2 | 1/6.2/60 | –5.39 |
14b | β-l-Glu | 11.6 ± 0.7 | 7.64 ± 0.64 | 1252 ± 70 | 1/0.7/108 | –5.39 |
15a | α-d-Ala | 0.69 ± 0.11 | 10.4 ± 0.01 | 71.5 ± 9.6 | 1/15/104 | –2.81 |
15b | β-d-Ala | 1.48 ± 0.08 | 11.3 ± 0.9 | 142 ± 33 | 1/7.6/96 | –2.81 |
16a | α-d-Val | 1.70 ± 0.09 | 1.93 ± 0.24 | 202 ± 3 | 1/1.1/119 | –1.94 |
16b | β-d-Val | 1.02 ± 0.07 | 1.68 ± 0.16 | 159 ± 17 | 1/1.6/156 | –1.94 |
17a | α-d-Phe | 0.61 ± 0.01 | 3.69 ± 0.59 | 76.4 ± 9.3 | 1/6.0/125 | –1.13 |
17b | β-d-Phe | 1.28 ± 0.38 | 1.19 ± 0.13 | 139 ± 23 | 1/0.9/109 | –1.13 |
18a | α-l-Chg | 1.23 ± 0.20 | 14.3 ± 0.09 | 177 ± 30 | 1/12/144 | –1.26 |
18b | β-l-Chg | 1.66 ± 1.04 | 1.30 ± 0.16 | 118 ± 23 | 1/0.8/71 | –1.26 |
19a | α-l-Abu | 0.76 ± 0.19 | 37.5 ± 3.4 | 144 ± 7 | 1/49/189 | –2.34 |
19b | β-l-Abu | 1.83 ± 0.04 | 1.30 ± 0.24 | 201 ± 10 | 1/0.7/110 | –2.34 |
20a | α-β-Ala | 1.30 ± 0.08 | 60.0 ± 1.9 | 182 ± 8 | 1/46/140 | –3.18 |
20b | β-β-Ala | 1.04 ± 0.04 | 13.9 ± 1.7 | 71.4 ± 4.6 | 1/13/69 | –3.18 |
21a | α-GABA | 0.77 ± 0.07 | 12.5 ± 0.7 | 45.6 ± 4.4 | 1/16/59 | –2.93 |
21b | β-GABA | 1.41 ± 0.13 | 6.61 ± 0.67 | 147 ± 13 | 1/4.7/104 | –2.93 |
22a | α-l-Val-l-Tyr | 0.82 ± 0.13 | 1.19 ± 0.42 | 69.0 ± 2.5 | 1/1.5/84 | –1.02 |
22b | β-l-Val-l-Tyr | 0.44 ± 0.01 | 1.38 ± 0.22 | 390 ± 49 | 1/3.1/886 | –1.02 |
23a | β-Gly-Gly | 4.62 ± 0.09 | 7.52 ± 0.43 | 203 ± 34 | 1/1.6/44 | –4.27 |
Determined in competition radioligand binding assays using rat brain membranes (MOR and DOR) and guinea-pig brain membranes (KOR). Values represent the mean ± SEM of three to four independent experiments each performed in duplicate.
Calculated using the MarvinSketch 18.8 (ChemAxon).
Data from ref (44).
Data from ref (49).